preclinical

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background
Biotech

Excellergy emerges with $70M and ex-Dermavant CEO at the helm

The California biotech is developing a new drug class in hopes of redefining the standard of care for several allergic diseases.
Gabrielle Masson Oct 13, 2025 10:50am
human brain abstract art

Angelini signs $550M-plus neuro pact with South Korean biotech

Sep 22, 2025 1:47pm
quit fire layoff workforce reduction exit

Flagship's Alltrna sheds staff as it readies for clinic

Aug 6, 2025 11:04am
Graphic of an open door with the words exit above it

Evotec makes 'strategic exit' from gene therapy space

May 22, 2024 9:22am
Stephane Bancel

Moderna CEO: Mpox vaccine development is not a high priority

Jan 4, 2023 9:49am
concept of chess board with letters MA

Blueprint drops $250M on Lengo for preclinical lung cancer med

Nov 29, 2021 10:20am